Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

TLR10 suppresses the activation and differentiation of monocytes with effects on DC-mediated adaptive immune responses.

Hess NJ, Felicelli C, Grage J, Tapping RI.

J Leukoc Biol. 2017 May;101(5):1245-1252. doi: 10.1189/jlb.3A1116-492R. Epub 2017 Feb 24.

2.

TLR10 Is a B Cell Intrinsic Suppressor of Adaptive Immune Responses.

Hess NJ, Jiang S, Li X, Guan Y, Tapping RI.

J Immunol. 2017 Jan 15;198(2):699-707. doi: 10.4049/jimmunol.1601335. Epub 2016 Dec 12.

3.

Resistance of Mice of the 129 Background to Yersinia pestis Maps to Multiple Loci on Chromosome 1.

Tencati M, Tapping RI.

Infect Immun. 2016 Sep 19;84(10):2904-13. doi: 10.1128/IAI.00488-16. Print 2016 Oct.

4.

TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling.

Jiang S, Li X, Hess NJ, Guan Y, Tapping RI.

J Immunol. 2016 May 1;196(9):3834-41. doi: 10.4049/jimmunol.1502599. Epub 2016 Mar 28.

5.

Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.

Mattis DM, Chervin AS, Ranoa DR, Kelley SL, Tapping RI, Kranz DM.

Mol Immunol. 2015 Dec;68(2 Pt A):203-12. doi: 10.1016/j.molimm.2015.08.008. Epub 2015 Aug 28.

6.
7.

The crystal structure of human soluble CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket.

Kelley SL, Lukk T, Nair SK, Tapping RI.

J Immunol. 2013 Feb 1;190(3):1304-11. doi: 10.4049/jimmunol.1202446. Epub 2012 Dec 21.

8.

Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria.

Hart BE, Tapping RI.

J Immunol. 2012 Dec 1;189(11):5347-55. doi: 10.4049/jimmunol.1201545. Epub 2012 Oct 26.

9.

Genetic Diversity of Toll-Like Receptors and Immunity to M. leprae Infection.

Hart BE, Tapping RI.

J Trop Med. 2012;2012:415057. doi: 10.1155/2012/415057. Epub 2012 Mar 18.

10.

Cell surface trafficking of TLR1 is differentially regulated by the chaperones PRAT4A and PRAT4B.

Hart BE, Tapping RI.

J Biol Chem. 2012 May 11;287(20):16550-62. doi: 10.1074/jbc.M112.342717. Epub 2012 Mar 23.

11.

Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening.

Guan Y, Omueti-Ayoade K, Mutha SK, Hergenrother PJ, Tapping RI.

J Biol Chem. 2010 Jul 30;285(31):23755-62. doi: 10.1074/jbc.M110.116046. Epub 2010 May 26.

12.

Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling.

Guan Y, Ranoa DR, Jiang S, Mutha SK, Li X, Baudry J, Tapping RI.

J Immunol. 2010 May 1;184(9):5094-103. doi: 10.4049/jimmunol.0901888. Epub 2010 Mar 26.

13.

Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization.

Sherry CL, Kim SS, Dilger RN, Bauer LL, Moon ML, Tapping RI, Fahey GC Jr, Tappenden KA, Freund GG.

Brain Behav Immun. 2010 May;24(4):631-40. doi: 10.1016/j.bbi.2010.01.015. Epub 2010 Feb 6.

14.

Toll-like receptor signaling in cell proliferation and survival.

Li X, Jiang S, Tapping RI.

Cytokine. 2010 Jan;49(1):1-9. doi: 10.1016/j.cyto.2009.08.010. Epub 2009 Sep 22. Review.

15.

Innate immune sensing and activation of cell surface Toll-like receptors.

Tapping RI.

Semin Immunol. 2009 Aug;21(4):175-84. doi: 10.1016/j.smim.2009.05.003. Epub 2009 Jun 2. Review.

PMID:
19493685
16.

Mapping of a microbial protein domain involved in binding and activation of the TLR2/TLR1 heterodimer.

Liang S, Hosur KB, Lu S, Nawar HF, Weber BR, Tapping RI, Connell TD, Hajishengallis G.

J Immunol. 2009 Mar 1;182(5):2978-85. doi: 10.4049/jimmunol.0803737.

17.

Characterization of the cell surface glycolipid from Spirochaeta aurantia.

Paul CJ, Lyle EA, Beveridge TJ, Tapping RI, Kropinski AM, Vinogradov E.

Glycoconj J. 2009 Dec;26(9):1097-108. doi: 10.1007/s10719-009-9230-4.

PMID:
19214746
18.

Heterogeneity of vaginal microbial communities within individuals.

Kim TK, Thomas SM, Ho M, Sharma S, Reich CI, Frank JA, Yeater KM, Biggs DR, Nakamura N, Stumpf R, Leigh SR, Tapping RI, Blanke SR, Slauch JM, Gaskins HR, Weisbaum JS, Olsen GJ, Hoyer LL, Wilson BA.

J Clin Microbiol. 2009 Apr;47(4):1181-9. doi: 10.1128/JCM.00854-08. Epub 2009 Jan 21.

19.

Proteolytic inactivation of tissue factor pathway inhibitor by bacterial omptins.

Yun TH, Cott JE, Tapping RI, Slauch JM, Morrissey JH.

Blood. 2009 Jan 29;113(5):1139-48. doi: 10.1182/blood-2008-05-157180. Epub 2008 Nov 6.

20.

Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Turner JK, Xu JL, Tapping RI.

Infect Immun. 2009 Jan;77(1):367-73. doi: 10.1128/IAI.01057-08. Epub 2008 Oct 27.

21.

The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17.

Turner JK, McAllister MM, Xu JL, Tapping RI.

Infect Immun. 2008 Sep;76(9):4092-9. doi: 10.1128/IAI.00488-08. Epub 2008 Jun 23.

22.

Genetic polymorphisms within the human Toll-like receptor 2 subfamily.

Tapping RI, Omueti KO, Johnson CM.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1445-8. Review.

PMID:
18031242
23.
24.

Genomic variants of TLR1--it takes (TLR-)two to tango.

Schumann RR, Tapping RI.

Eur J Immunol. 2007 Aug;37(8):2059-62. Review.

25.

Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.

Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI.

J Immunol. 2007 Jun 15;178(12):7520-4.

26.

The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components.

Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI.

J Immunol. 2007 May 15;178(10):6387-94.

27.

Acute hypoxia activates the neuroimmune system, which diabetes exacerbates.

Johnson DR, O'Connor JC, Hartman ME, Tapping RI, Freund GG.

J Neurosci. 2007 Jan 31;27(5):1161-6.

28.

Ganglioside GD1a is an essential coreceptor for Toll-like receptor 2 signaling in response to the B subunit of type IIb enterotoxin.

Liang S, Wang M, Tapping RI, Stepensky V, Nawar HF, Triantafilou M, Triantafilou K, Connell TD, Hajishengallis G.

J Biol Chem. 2007 Mar 9;282(10):7532-42. Epub 2007 Jan 16.

29.

Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus.

Hajishengallis G, Tapping RI, Harokopakis E, Nishiyama S, Ratti P, Schifferle RE, Lyle EA, Triantafilou M, Triantafilou K, Yoshimura F.

Cell Microbiol. 2006 Oct;8(10):1557-70.

PMID:
16984411
30.

Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination.

Omueti KO, Beyer JM, Johnson CM, Lyle EA, Tapping RI.

J Biol Chem. 2005 Nov 4;280(44):36616-25. Epub 2005 Aug 29.

31.

Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins.

Hajishengallis G, Tapping RI, Martin MH, Nawar H, Lyle EA, Russell MW, Connell TD.

Infect Immun. 2005 Mar;73(3):1343-9.

32.

The structure and biological characteristics of the Spirochaeta aurantia outer membrane glycolipid LGLB.

Vinogradov E, Paul CJ, Li J, Zhou Y, Lyle EA, Tapping RI, Kropinski AM, Perry MB.

Eur J Biochem. 2004 Dec;271(23-24):4685-95.

33.
34.

Investigating the cellular BMK1/ERK5 signaling pathway.

Tapping RI, Yutaka K, Chao TH, Hayashi M, Lo JF, Kim SW, Lee JD.

Methods Mol Biol. 2004;250:89-96. No abstract available.

PMID:
14755081
35.
36.

Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.

Werts C, Tapping RI, Mathison JC, Chuang TH, Kravchenko V, Saint Girons I, Haake DA, Godowski PJ, Hayashi F, Ozinsky A, Underhill DM, Kirschning CJ, Wagner H, Aderem A, Tobias PS, Ulevitch RJ.

Nat Immunol. 2001 Apr;2(4):346-52.

PMID:
11276206
37.

BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase.

Hayashi M, Tapping RI, Chao TH, Lo JF, King CC, Yang Y, Lee JD.

J Biol Chem. 2001 Mar 23;276(12):8631-4. Epub 2001 Jan 31.

38.

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS.

J Immunol. 2000 Nov 15;165(10):5780-7.

39.

Role of BMK1 in regulation of growth factor-induced cellular responses.

Kato Y, Chao TH, Hayashi M, Tapping RI, Lee JD.

Immunol Res. 2000;21(2-3):233-7. Review.

PMID:
10852122
40.

Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.

Kato Y, Zhao M, Morikawa A, Sugiyama T, Chakravortty D, Koide N, Yoshida T, Tapping RI, Yang Y, Yokochi T, Lee JD.

J Biol Chem. 2000 Jun 16;275(24):18534-40.

41.

Soluble CD14-mediated cellular responses to lipopolysaccharide.

Tapping RI, Tobias PS.

Chem Immunol. 2000;74:108-21. Review. No abstract available.

PMID:
10608084
42.

MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway.

Chao TH, Hayashi M, Tapping RI, Kato Y, Lee JD.

J Biol Chem. 1999 Dec 17;274(51):36035-8.

43.
44.

Endotoxin interactions with lipopolysaccharide-responsive cells.

Tobias PS, Tapping RI, Gegner JA.

Clin Infect Dis. 1999 Mar;28(3):476-81. Review.

PMID:
10194064
45.

Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor.

Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD.

Nature. 1998 Oct 15;395(6703):713-6.

PMID:
9790194
46.

Binding of bacterial peptidoglycan to CD14.

Dziarski R, Tapping RI, Tobias PS.

J Biol Chem. 1998 Apr 10;273(15):8680-90.

47.

Roles for LBP and soluble CD14 in cellular uptake of LPS.

Tapping RI, Gegner JA, Kravchenko VV, Tobias PS.

Prog Clin Biol Res. 1998;397:73-8. Review.

PMID:
9575548
48.

BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.

Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD.

EMBO J. 1997 Dec 1;16(23):7054-66.

49.
50.

Supplemental Content

Loading ...
Support Center